Two Sigma Securities LLC cut its holdings in Humana Inc. (NYSE:HUM - Free Report) by 66.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,781 shares of the insurance provider's stock after selling 11,642 shares during the quarter. Two Sigma Securities LLC's holdings in Humana were worth $1,467,000 as of its most recent SEC filing.
Other hedge funds also recently made changes to their positions in the company. Transcend Capital Advisors LLC lifted its position in Humana by 399.7% in the 4th quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider's stock worth $924,000 after buying an additional 2,914 shares in the last quarter. FNY Investment Advisers LLC increased its position in Humana by 6,647.5% during the fourth quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider's stock worth $6,916,000 after acquiring an additional 26,856 shares during the period. Retirement Systems of Alabama raised its position in shares of Humana by 735.9% during the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider's stock valued at $55,563,000 after buying an additional 192,801 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its stake in Humana by 7.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider's stock worth $244,811,000 after buying an additional 65,735 shares in the last quarter. Finally, Secure Asset Management LLC acquired a new position in Humana in the fourth quarter worth about $244,000. Institutional investors and hedge funds own 92.38% of the company's stock.
Wall Street Analysts Forecast Growth
Several brokerages have recently commented on HUM. JPMorgan Chase & Co. reduced their target price on shares of Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a research note on Tuesday, February 18th. Guggenheim began coverage on shares of Humana in a research note on Wednesday, April 9th. They set a "buy" rating and a $326.00 price target for the company. Cantor Fitzgerald reaffirmed a "neutral" rating and set a $290.00 target price on shares of Humana in a report on Wednesday, February 12th. Mizuho upped their target price on shares of Humana from $305.00 to $316.00 and gave the company an "outperform" rating in a research report on Wednesday, April 9th. Finally, Truist Financial raised their price target on Humana from $290.00 to $325.00 and gave the stock a "hold" rating in a research report on Friday, April 11th. Seventeen research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and an average target price of $284.90.
Check Out Our Latest Stock Analysis on HUM
Humana Stock Down 1.5 %
Shares of HUM traded down $3.91 during mid-day trading on Friday, hitting $263.92. 1,097,942 shares of the company's stock were exchanged, compared to its average volume of 1,747,221. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $406.46. The company has a market cap of $31.85 billion, a PE ratio of 26.52, a P/E/G ratio of 2.05 and a beta of 0.62. The company has a 50-day simple moving average of $266.35 and a 200 day simple moving average of $270.81.
Humana (NYSE:HUM - Get Free Report) last released its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating analysts' consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, research analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.
Humana Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, June 27th. This represents a $3.54 annualized dividend and a dividend yield of 1.34%. Humana's dividend payout ratio is presently 35.58%.
Humana Profile
(
Free Report)
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Further Reading

Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.